Offering a full range of clinical pharmacology solutions spanning proof of concept studies, bioavailability, PK/PD, drug-drug interaction, food effect, bioequivalence, and special population studies, our purpose-built clinic allows for the seamless conduct of a huge range of trials.

Led by highly experienced Ondrej Palan, the success of the QUINTA-ANALYTICA’s Clinical Department is attested to the rapid screening and recruitment of healthy volunteers, experienced medical staff licensed in clinical pharmacology, internal medicine, oncology, diabetology, anesthesiology, and intensive care, and unparalleled cooperation.

Boasting a database that includes more than 15,000 volunteers, the dept. makes concerted strides to understand its clients’ exact needs and their protocol requirements, and then execute those in a meticulous, quality-driven, client-focused manner.

Operating in English, Czech, and via our joint-venture laboratory, Russian languages, the dept. has excellent relationships with all regulatory bodies and has a harmonized clinical and QA approach across the organization.

With volunteer safety always a top priority, exigent safety measures, and a specific set of rules regarding SARS CoV-2 protection guarantee a successful clinical trial.

Get in touch with us to learn more!

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.